MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $739,400 | -52.3% | 5,063 | -24.6% | 0.00% | – |
| Q2 2023 | $1,551,627 | +388.5% | 6,717 | +412.4% | 0.00% | – |
| Q1 2023 | $317,603 | -23.5% | 1,311 | -8.4% | 0.00% | – |
| Q4 2022 | $415,000 | -53.5% | 1,431 | -85.4% | 0.00% | – |
| Q4 2019 | $892,000 | -5.9% | 9,787 | -11.0% | 0.00% | – |
| Q3 2019 | $948,000 | +40.4% | 10,996 | +70.9% | 0.00% | – |
| Q2 2019 | $675,000 | -25.6% | 6,436 | -11.1% | 0.00% | – |
| Q1 2019 | $907,000 | +12.4% | 7,241 | +1.2% | 0.00% | – |
| Q4 2018 | $807,000 | -14.9% | 7,156 | +61.7% | 0.00% | – |
| Q3 2018 | $948,000 | -56.2% | 4,426 | -42.7% | 0.00% | -100.0% |
| Q2 2018 | $2,162,000 | +107.9% | 7,728 | -13.2% | 0.00% | – |
| Q1 2018 | $1,040,000 | -44.1% | 8,905 | -56.1% | 0.00% | -100.0% |
| Q4 2017 | $1,859,000 | – | 20,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |